Background
Drug-coated balloons (DCBs) have shown efficacy for treatment of coronary artery disease. In the PEPCAD II ISR trial, paclitaxel-coated balloon (PCB) reduced in-stent restenosis (ISR) compared with paclitaxel-eluting stent (PES). Here we evaluated the efficacy of PCB in a porcine ISR model.
Materials and methods
Thirty-two coronary arteries (LAD: n =12, LCX: n =11, RCA: n =9) of 24 Yorkshire pigs were assigned to two groups randomly. PCB (SeQuent, length 20 mm, n =16) or noncoated balloon (NCB, length 20 mm, n =16) was inflated for 60 s with B:A 1.2:1 followed by BMS (length 12 mm) implantation (S/A 1.5:1) within the target region. At 28 days, animals underwent restudy for the assessment of quantitative coronary angiography (QCA) and optical coherence tomography (OCT).

Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree

